What is the Cartiva SCI Device?
The Cartiva Synthetic Cartilage Implant (commonly referred to as Cartiva SCI) is an implant designed for the treatment of osteoarthritis in the big toe joint. The implant is made of a hydrogel polymer intended to mimic cartilage and maintain joint mobility while reducing pain. The device was designed as an alternative to fusion surgery that preserves motion in the joint and reduces pain. However, the device has been associated with significant complications, leading to adverse outcomes in many patients.
Recall of the Cartiva SCI
In October 2024, Stryker, the manufacturer of the Cartiva SCI, issued a recall after post-market studies indicated higher-than-expected rates of complications. These included implant subsidence (the device sinking into the bone), fractures, painful cysts, and an increased need for revision surgeries. Patients and healthcare providers were advised to monitor for symptoms such as worsening pain, difficulty walking, or joint instability​.
Read the Stryker recall notice: Urgent: Medical Device Recall – Cartiva Synthetic Cartilage Implant.
Canadians can view the most recent recall details via the Government of Canada Recalls and Alerts database.
Legal Action in Canada
Murphy Battista LLP has filed a proposed class action lawsuit against Cartiva Inc., Stryker Canada ULC, and Wright Medical Technology Canada ULC on behalf of Canadians harmed by the Cartiva SCI. The case alleges that the device was defective and failed to meet safety standards, causing harm and additional medical expenses for patients. This lawsuit seeks compensation for injuries, pain and suffering, revision surgeries, loss of income, care expenses, and other losses caused by the defective implant​.
Problems Linked to the Cartiva SCI
The following complications have been reported among individuals with Cartiva SCI implants:
- Infections
- Implant failure or fractures
- Subsidence (sinking of the implant into the bone)
- Osteolysis (bone breakdown around the implant)
- Painful cysts
- Silastic granulomas (painful lumps forming around the implant)
- Need for toe fusion, replacement surgery, or revision surgery.
These complications often result in additional pain, limited mobility, and further medical intervention.
Frequently Asked Questions About Cartiva SCI Issues
1. Who is affected?
Any individual in Canada who received the Cartiva SCI implant may be affected by the recall and be eligible to participate in the class action.
2. Why was the device recalled?
Post-market data revealed high rates of complications not fully identified by the manufacturer.
3. What should I do if I experience symptoms?
Contact your healthcare provider to evaluate your implant and determine necessary steps.
4. Is financial compensation available?
This class action aims to obtain compensation for Canadians who have received the Cartiva implant, whether they are experiencing any symptoms or not.
5. Am I eligible for compensation?
If you have experienced complications or required further surgeries due to a Cartiva SCI, you may qualify for the class action lawsuit. If you think you may be eligible, or if you have received a Cartiva implant, you can follow the link below to find out more.
How to Join the Class Action
Canadians affected by the Cartiva SCI are encouraged to submit their information to Murphy Battista LLP using the questionnaire available here. Submitting the questionnaire ensures you will be added to the database for potential claimants and kept updated on the progress of the litigation.
For inquiries, email [email protected] to learn more about joining the class action.